Luteal support (progesterone) after transfer

After embryo transfer, almost all patients take progesterone — the so-called luteal support. It is one of the most common questions: why do I need it, how do I take it and for how long?

Progesterone is the hormone that prepares and maintains the endometrium so that it can receive the embryo. Its correct administration is an essential part of treatment, but the details depend on the type of cycle.

Why is progesterone needed after embryo transfer?

In a natural pregnancy, the corpus luteum that forms after ovulation produces progesterone, which keeps the endometrium suitable for implantation. In IVF with fresh transfer, the ovarian stimulation and the way ovulation is triggered disturb this natural production.

For that reason, in fresh cycles supplementary progesterone is essential: it compensates for the inadequate function of the corpus luteum and has been shown to improve the pregnancy and birth rate.

In what ways is it given?

Progesterone is given mainly in three ways: vaginally (pessaries, capsules or gel), intramuscularly (injection in an oil solution) and subcutaneously (injection). The vaginal route is the most widespread, because it is simple, acts locally on the uterus and avoids the pain of intramuscular injections.

Studies show that the three routes are broadly equally effective for pregnancy. The choice is made chiefly on the basis of tolerability, convenience and patient preference.

Is progesterone needed in frozen transfer too?

It depends on the type of cycle. In the medicated (programmed) frozen-transfer cycle there is no corpus luteum, so progesterone is absolutely essential and in an adequate dose — the pregnancy depends entirely on it.

In the true natural cycle, by contrast, the corpus luteum is present and produces progesterone on its own. There, the need for extra administration is theoretically smaller, although many centres give a supplementary dose for reassurance.

When does progesterone start and when does it stop?

Progesterone usually starts around the day of egg retrieval (in fresh cycles) or a few days before transfer (in frozen cycles), so that the endometrium is synchronized with the embryo’s stage.

It continues at least until the pregnancy test. If the test is positive, many protocols continue it for a few more weeks, until the placenta takes over production. The exact time of stopping is decided by your doctor.

Does it have side effects?

Progesterone is generally well tolerated. In the vaginal form, it can cause local irritation, discharge or discomfort. In the intramuscular form, the injections can be painful and cause local tenderness or hardening.

More general symptoms, such as mild bloating, breast tenderness or drowsiness, are possible but usually mild. It is important not to stop progesterone on your own without instruction, especially in medicated cycles.

What is the key message?

Luteal support with progesterone is a fundamental, evidence-based part of IVF in fresh and medicated cycles. The route of administration matters little for effectiveness — you choose the one that suits you best, in consultation with your doctor.

What matters most is consistency: taking the progesterone correctly and for as long as prescribed, especially when there is no corpus luteum to replace it.

Summary

Progesterone after embryo transfer prepares and maintains the endometrium for implantation. In fresh cycles and in medicated frozen-transfer cycles it is essential, because the corpus luteum is absent or underactive. In the true natural cycle, where the corpus luteum produces progesterone, the need is theoretically smaller. The three routes of administration — vaginal, intramuscular, subcutaneous — are equally effective; the choice is made on tolerability and convenience. The key is correct and consistent use for as long as prescribed.

Sources: van der Linden et al., Cochrane Database of Systematic Reviews — “Luteal phase support for assisted reproduction cycles”; ESHRE Guideline “Ovarian Stimulation for IVF/ICSI” (progesterone doses and routes).

⚕ Medically reviewed by Prof. Stratis Kolibianakis · Thessaloniki Medical Association Reg. No. 16340

ARTICLE 9 · MALE INFERTILITY